Akebia Therapeutics Cash from Financing (TTM) Insights

Akebia Therapeutics Inc (AKBA)

1.335 0.00 (0.00%) USD | NASDAQ | Apr 26, 10:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-25.21M
September 30, 2023	-23.92M
June 30, 2023	-56.90M
March 31, 2023	-48.91M
December 31, 2022	14.60M
September 30, 2022	20.00M
June 30, 2022	69.42M
March 31, 2022	106.80M
December 31, 2021	133.73M
September 30, 2021	158.84M
June 30, 2021	143.41M
March 31, 2021	248.85M
December 31, 2020	231.72M
September 30, 2020	295.63M
June 30, 2020	294.77M
March 31, 2020	160.76M
December 31, 2019	88.97M
September 30, 2019	-5.363M
June 30, 2019	-5.204M
March 31, 2019	-13.80M
December 31, 2018	96.56M

Date	Value
September 30, 2018	101.72M
June 30, 2018	165.15M
March 31, 2018	210.40M
December 31, 2017	116.24M
September 30, 2017	114.53M
June 30, 2017	53.07M
March 31, 2017	7.51M
December 31, 2016	66.95M
September 30, 2016	67.76M
June 30, 2016	79.38M
March 31, 2016	144.23M
December 31, 2015	83.09M
September 30, 2015	78.70M
June 30, 2015	64.63M
March 31, 2015	-1.305M
December 31, 2014	104.40M
September 30, 2014	104.23M
June 30, 2014	104.32M
March 31, 2014	145.60M
December 31, 2013	42.33M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-56.90M

Minimum

Jun 2023

295.63M

Maximum

Sep 2020

94.84M

Average

88.97M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks